alopecia areata also known spot baldness condition hair lost areas often results bald spots scalp size psychological stress illness possible factors bringing alopecia areata individuals risk cases obvious people generally otherwise cases hair scalp lost alopecia totalis body hair lost alopecia universalis hair loss permanent alopecia areata believed autoimmune disease resulting breach immune privilege hair risk factors include family history among identical twins one affected chance also underlying mechanism involves failure body recognize cells subsequent immunemediated destruction hair cure condition treatments particularly triamcinolone injections minoxidil topical effective speeding hair sunscreen head coverings protect cold sun glasses eyelashes missing also cases suddenonset localized patchy disease hair regrows within patients one two patches oneyear recovery occur however people one episode course many patients hair loss regrowth occurs simultaneously course several among body hair lost fewer people affected one time people affected point onset usually females affected higher rates typical first symptoms alopecia areata small bald patches underlying skin unscarred looks superficially normal although patches take many shapes usually round alopecia areata often affects scalp beard may occur part body different areas skin may exhibit hair loss regrowth time disease may also go remission time may permanent common childrencitation needed area hair loss may tingle mildly hair tends fall short period time loss commonly occurring one side scalp exclamation point hairs narrower along length strand closer base producing characteristic exclamation point appearance often hairs short mm seen surrounding bald healthy hair pulled come ripped hair distributed evenly across tugged portion scalp cases alopecia areata hair tends pull easily along edge patch follicles already attacked bodys immune system away patch still nails may pitting alopecia areata thought systemic autoimmune disorder body attacks anagen hair follicles suppresses stops hair example cell lymphocytes cluster around affected follicles causing inflammation subsequent hair loss hair follicles normal state thought kept secure immune system phenomenon called immune privilege breach immune privilege state considered cause alopecia cases babies born congenital alopecia areata recognized type inflammatory alopecia areata occurs frequently people affected family members suggesting heredity may strong evidence genetic association increased risk alopecia areata found studying families two affected members study identified least four regions genome likely contain addition alopecia areata shares genetic risk factors autoimmune diseases including rheumatoid arthritis type diabetes celiac may manifestation celiac endogenous retinoids metabolic defect key part pathogenesis alopecia genomewide association study completed identified single nucleotide polymorphisms associated alopecia areata genes identified include involved controlling activation proliferation regulatory cells cytotoxic lymphocyteassociated antigen receptor eos also known ikaros family zinc finger well human leukocyte antigen study also identified two genes expressed hair psychodermatological connection noted impairment psychiatric comorbidities including mental wellbeing self esteem mental disorders acting pathogenic triggers alopecia alopecia areata usually diagnosed based clinical features trichoscopy may aid establishing diagnosis alopecia areata trichoscopy shows regularly distributed yellow dots hyperkeratotic plugs small exclamationmark hairs black dots destroyed hairs hair follicle oftentimes however discrete areas hair loss surrounded exclamation mark hairs sufficient clinical diagnosis alopecia areata sometimes reddening skin erythema may also present balding biopsy rarely needed make diagnosis aid management alopecia areata histologic findings may include peribulbar lymphocytic infiltration resembling swarm bees shift anagentotelogen ratio towards telogen dilated follicular helpful findings include pigment incontinence hair bulb follicular stelae occasionally inactive alopecia areata inflammatory infiltrates foundcitation needed commonly alopecia areata involves hair loss one round spots alopecia areata totalis universalis objective assessment treatment efficacy difficult spontaneous remission unpredictable affected area patchy hair may regrow spontaneously many none existing therapeutic options curative systematic review showed greater hair regrowth patients treated mgml triamcinolone cochranestyle systematic review published showed topical minoxidil associated hair regrowth months compared cases severe hair loss limited success achieved using corticosteroid medications clobetasol fluocinonide injection cream application corticosteroid creams affected skin less effective takes longer produce results steroid injections commonly used sites areas hair loss head small especially eyebrow hair lost whether effective uncertaincitation needed medications used minoxidil elocon mometasone ointment steroid cream irritants anthralin topical coal tar topical immunotherapy ciclosporin sometimes different combinations topical corticosteroids frequently fail enter skin deeply enough affect hair bulbs treatment small lesions typically also regrow spontaneously oral corticosteroids may decrease hair loss period taken medications cause serious side one treatment effective cases individuals may show response severe cases studies shown promising results individual use immunosuppressant methotrexate adjunct use alopecia areata associated celiac disease treatment glutenfree diet allows complete permanent regrowth scalp body hair many people others remissions recurrences improvement probably due normalization immune response result gluten withdrawal june us food drug administration fda authorized baricitinib janus kinase jak inhibitor treatment severe alopecia ritlecitinib litfulo approved medical use united states june fecal matter transplants fmt shown reverse aa support hair growth long lasting results even going far growing additional hair arms face grey hairs even regained colour supports idea connection gut microbiota part hair cases begin small number patches hair loss hair grows back months cases greater number patches hair either grow back progress alopecia areata totalis rare cases alopecia areata loss body function occurs effects alopecia areata psychological loss selfimage due hair loss although severe loss hair also means scalp burns easily sun patients may also aberrant nail formation keratin forms hair nailscitation needed hair may grow back fall later may indicate recurrence condition rather natural cycle growthandshedding relatively synchronised start pattern fade time episodes alopecia areata puberty predispose chronic recurrence alopecia cause psychological stress hair loss lead significant changes appearance individuals may experience social phobia anxiety condition affects population lifetime risk common alopecia areata occurs people otherwise healthy skin initial presentation commonly occurs early childhood late teenage years young adulthood happen patients also tend slightly higher incidence conditions related immune system asthma allergies atopic dermatitis hypothyroidism term alopecia used physicians dating back hippocrates originates greek word fox alopex sonamed due fur loss seen fox mange areata derived latin word area meaning vacant space alopecia areata alopecia barbae identified biblical nethek condition part greater tzaraath family skin disorders said disorders purported discussed book leviticus chapter actor christopher reeve suffered skin nascar driver joey logano nfl quarterback josh dobbs obstacle athlete kevin politicians peter ayanna kpop singer peniel shin actors anthony alan actresses jada pinkett may form alopecia areata many medications preliminary findings showing oral ruxolitinib drug approved us food drug administration fda bone marrow disorder myelofibrosis restored hair growth three individuals longstanding severe march us fda granted breakthrough therapy designation baricitinib systematic treatment alopecia granted approval june efficacy rate people hair loss reaching scalp coverage acts inhibitor janus kinase jak blocking subtypes httpsenwikipediaorgwikialopeciaareata